Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study
2024 · Molecular Therapy · 22 citations
https://doi.org/10.1016/j.ymthe.2024.04.029
K
Kun Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
2.3K
Citations
16
h-index
18
i10-index
Kun Chen is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Colorectal Cancer Screening and Detection. The author has an h-index of 16, co-authored 37 publications.
ORCID: 0000-0003-0577-0998Papers by this author
worksLower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM)
2022 · Journal of Immunotherapy · 16 citations
https://doi.org/10.1097/cji.0000000000000421
Identification of a novel subtype of SPP1 + macrophages expressing SIRPα: implications for tumor immune evasion and treatment response prediction
2024 · Experimental Hematology and Oncology · 7 citations
https://doi.org/10.1186/s40164-024-00587-3
Abnormal generation of IL-17A represses tumor infiltration of stem-like exhausted CD8+ T cells to demote the antitumor immunity
2023 · BMC Medicine · 6 citations
https://doi.org/10.1186/s12916-023-03026-y
Primary malignant melanoma of breast presenting as ulcerated nipple and breast lump: A rare case report
2022 · Asian Journal of Surgery · 0 citations
https://doi.org/10.1016/j.asjsur.2022.01.114
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat